We find that increasing the NAD+/NADH balance or overexpressing the NAD+-dependent mitochondrial deacetylase SIRT3, but not SIRT4 or SIRT5, hinder tumorigenicity in neurofibromin-deficient cells, including highly aggressive MPNST models. This evidence concerns the gene SIRT4 and malignant peripheral nerve sheath tumor.